Correspondence
Professor Erik Melén Telephone: +46-(0)8-524-875-08.
E-mail: erik.melen@ki.se
Key words: peanut allergy, oral immunotherapy, Omalizumab, Xolair, RNA-sequencing, gene expression, adolescences